COMBINATION OF LOTEPREDNOL AND BETA2 ADRENOZEPTOR AGONISTS AND THEIR USE THROUGH INHALATION TO TREAT ASTHMA BRONCHIALE

摘要

The invention relates to a novel combination of a soft steroid, in particular loteprednol, and at least one beta2 adrenoceptor agonist for the simultaneous, sequential or separate treatment of allergies and/or airway disorders, medicaments comprising the combination, processes for the production of such medicaments and the use of the novel combination for the production of medicaments for the simultaneous, sequential or separate treatment of allergies and/or airway disorders.